Henry T Stratton

Title: The Innovations of Henry T Stratton

Introduction

Henry T Stratton is a notable inventor based in Glendale, Wisconsin. He has made significant contributions to the field of medicine, particularly in the prevention of renal failure. His innovative approach has garnered attention and recognition within the medical community.

Latest Patents

Stratton holds a patent for a method that utilizes prostaglandin E1, E2, or their analogs to prevent renal failure induced by medical tests that utilize contrast media. This method involves administering a prostaglandin selected from PGE.sub.1, PGE.sub.2, PGI.sub.2, or an analog or pharmaceutically acceptable salt thereof, preferably in a complex with .alpha.-cyclodextrin, to patients at risk, such as diabetics. This patent highlights his commitment to improving patient outcomes in medical procedures.

Career Highlights

Stratton is associated with Schwarz Pharma Limited, where he has been able to apply his expertise in pharmacology and medical innovation. His work has not only advanced medical practices but has also contributed to the overall understanding of renal health.

Collaborations

Some of his notable coworkers include Tammy K Antonucci and Erwin Schollmayer. Their collaborative efforts have likely played a role in the development and refinement of his innovative methods.

Conclusion

Henry T Stratton's contributions to medical innovation, particularly in preventing renal failure, demonstrate his dedication to improving healthcare. His patent reflects a significant advancement in medical technology that can benefit many patients at risk.